Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

scPharmaceuticals Announced Non-dilutive Financings Totaling Up To $125M From Perceptive Advisors

Author: Benzinga Newsdesk | August 12, 2024 06:08am
  • scPharmaceuticals received $75 million through a combination of debt and royalty financings at close, with access to an additional $50 million
  • The term loan refinances existing debt principal; lowers coupon, extends interest-only period for four additional years, and lowers minimum cash requirement to $5 million

Posted In: SCPH

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist